Analyst price target range
Janux Therapeutics Price Target: $36.24 Average
Direct answer
Janux Therapeutics's average price target is $36.24.
The verified analyst range runs from $14.00 to $75.00.
The low target implies -14.8%, the high target implies +356.2%, and the range spans 371% of the current price.
Forecast evidence checked September 16, 2026.
Get free Janux Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $16.44
- Average price target
- $36.24
- High price target
- $75.00
- Low price target
- $14.00
- Low target gap
- -14.8%
- Target upside
- +120.4%
- High target gap
- +356.2%
- Target range width
- 371%
- Consensus rating
- Strong Buy
- Analysts
- 17
- Evidence date
- September 16, 2026
- Valid through
- September 23, 2026
Explore related company data
Read the frequently asked questions.
What is Janux Therapeutics's average price target?
Janux Therapeutics's verified average price target is $36.24. The target range is $14.00 to $75.00.
How far are Janux Therapeutics's low and high targets from the recorded price?
The low target implies -14.8%, while the high target implies +356.2%.
How many analysts are included in Janux Therapeutics's consensus?
The verified consensus includes 17 analysts.
How is Janux Therapeutics's target upside or downside calculated?
The average target of $36.24 is divided by the recorded price of $16.44, then one is subtracted to produce +120.4%. This does not guarantee a future return.
When was Janux Therapeutics's analyst forecast verified?
The data was verified on 2026-09-16. The dataset is valid through 2026-09-23.